SCHEMBL28296127

SCHEMBL28296127

COC(=O)C1=CC=CNC=N1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.34
KDM4E B2RXH2 5/20 0.33
GAA P10253 2/20 0.33
XDH P47989 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
NFKB1 P19838 1/20 0.33
GFER P55789 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
FUT7 Q11130 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPK1 P28482 1/20 0.33
TSHR P16473 2/20 0.33
GLA P06280 1/20 0.33
MAPT P10636 1/20 0.32
CA12 O43570 4/20 0.32
CA1 P00915 4/20 0.32
CA2 P00918 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6209355 0.79
SCHEMBL12471891 0.72 NPSR1 (0.35) NPSR1KDM4EGAAXDHTDP1
SCHEMBL29065453 0.71 NPSR1 (0.38) NPSR1KDM4EGAAXDHTDP1
SCHEMBL22747796 0.69 SLC22A6 (0.30)
SCHEMBL29065452 0.69 NPSR1 (0.44) NPSR1KDM4EGAAXDHTDP1
SCHEMBL5552219 0.68 KDM4E (0.33) NPSR1KDM4EGAAXDHTDP1
SCHEMBL29065451 0.68 NPSR1 (0.35) NPSR1KDM4EGAAXDHTDP1
SCHEMBL31435414 0.67 NPSR1 (0.34) NPSR1KDM4EGAAXDHTDP1
SCHEMBL28474643 0.67 NPSR1 (0.34) NPSR1KDM4EGAAXDHTDP1
SCHEMBL30415854 0.67 NPSR1 (0.34) NPSR1KDM4ETDP1MAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843892-B Oxadiazepinone derivatives and their use in the treatment of hepatitis B infections 诺维拉治疗公司 2022-01-25 CN disclosed
CN-109843892-A Dislike diazepine ketone derivatives and its purposes in treatment hepatitis B infection 诺维拉治疗公司 2019-06-04 CN disclosed